This proceedings is part of an ongoing CME/CE initiative to provide grouping on kind changes reported by the FDA.
Activities of this level will be posted on Medscape on a weekly dry land.
July 19, 2007
This is a part of article FDA Safety Changes: Sarafem/Prozac, Avandamet, Focalin XR. Taken from "Prozac Fluoxetine Generic" Information Blog
Friday, June 27, 2008
FDA Safety Changes: Sarafem/Prozac, Avandamet, Focalin XR.
Subscribe to:
Post Comments (Atom)
No comments:
Post a Comment